Agios Pharmaceuticals Inc (STU:8AP)
€ 34.2 -3 (-8.06%) Market Cap: 1.93 Bil Enterprise Value: 1.03 Bil PE Ratio: 3.01 PB Ratio: 1.20 GF Score: 50/100

Q1 2023 Agios Pharmaceuticals Inc Earnings Call Transcript

May 04, 2023 / 12:00PM GMT
Release Date Price: €20.6 (+0.98%)
Operator

Good morning, and welcome to Agios' First Quarter 2023 Conference Call. (Operator Instructions) Please be advised that this call is being recorded at Agios' request. I would now like to turn the call over to Agios' Chief Financial Officer, Cecilia Jones. Please go ahead.

Cecilia Jones
Agios Pharmaceuticals, Inc. - CFO

Thank you, operator. Good morning, everyone, and welcome to Agios first quarter 2023 conference call. You can access slides for today's call by going to the Investors section of our website, agios.com.

On today's call, I am joined our Chief Executive Officer, Brian Goff; Dr. Sarah Gheuens, our Chief Medical Officer and Head of Research and Development; and Tsveta Milanova, our Chief Commercial Officer.

Before we get started, I would like to remind everyone that some of the statements we make on this call will include forward-looking statements. Actual events and results could differ materially from those expressed or implied by any forward-looking statements as a result of various risks, uncertainties and other factors,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot